TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Vaccinium Invest AB
Closing information (x1000 EUR)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
2,134
|
4,004
|
0 |
| Financial expenses |
0
|
0
|
15 |
| Earnings before taxes |
1,227
|
479
|
-12 |
| EBITDA |
333
|
-55
|
-2 |
| Total assets |
1,215
|
877
|
384 |
| Current assets |
1,203
|
864
|
369 |
| Current liabilities |
77
|
0
|
0 |
| Equity capital |
1,138
|
877
|
384 |
| - share capital |
4
|
4
|
5 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
93.7%
|
100%
|
100% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
57.5%
|
12.0% | |
| Return on assets (ROA) |
101.0%
|
54.6%
|
0.8% |
| Current ratio | 1562.3% | ||
| Return on equity (ROE) |
107.8%
|
54.6%
|
-3.1% |
| Change turnover |
-1,723
|
4,004
|
0 |
| Change turnover % | -45% | ||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.